COX-2 Inhibitor Screening Kit, Catalog: MA-0212


100 wells, Fluorometric, Ex/Em = 535/587 nm


Catalog MA-0212

Size 100 wells

Sample Type Test Inhibitor compounds

Method of Detection Fluorometric, Ex/Em = 535/587 nm

Assay Type Quantitative

Application A simple sensitive plate based assay to test compounds for their effects on COX-2.

Storage Conditions -20°C

Shipping Temperature Gel Pack

Shelf Life One year from the date of delivery


Cyclooxygenase converts arachidonic acid into prostaglandins. The enzyme has two distinct activities, cyclooxygenase and peroxidase activity. There are also two isozymes, COX-1 and COX-2. While COX-2 is constitutive at a low level in some tissues (kidney, brain, female reproductive system), its importance lies in its inducible nature, with significant upregulation in response to inflammatory stimuli. Inflammation is a necessary process for host defense and tissue repair, but dysregulation leads to chronic autoinflammatory diseases such as arthritis and inflammatory bowel disease, where sustained overexpression leads to persistent inflammation and tissue damage. COX-2 plays a role in regulating blood flow and renal function and is implicated in some types of cancer, associated with tumor growth, angiogenesis and metastasis. Selective COX-2 inhibitors have been developed to bind COX-2 without affecting COX-1 but their use has an increased risk of cardiovascular events such as myocardial infarct and stroke. AkrivisBio’s COX-2 Inhibitor Screening Kit is a simple sensitive way to test compounds for their effects on COX-2.